The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Open accessAbstract
Otto Warburg's theory on the origins of cancer postulates that tumor cells have defects in mitochondrial oxidative phosphorylation and therefore rely on high levels of aerobic glycolysis as the major source of ATP to fuel cellular proliferation (the Warburg effect). This is in contrast to normal cells, which primarily utilize oxidative phosphorylation for growth and survival. Here we report that the major function of glucose metabolism for Kras-induced anchorage-independent growth, a hallmark of transformed cells, is to support the pentose phosphate pathway. The major function of glycolytic ATP is to support growth under hypoxic conditions. Glutamine conversion into the tricarboxylic acid cycle intermediate alpha-ketoglutarate through glutaminase and alanine aminotransferase is essential for Kras-induced anchorage-independent growth. Mitochondrial metabolism allows for the generation of reactive oxygen species (ROS) which are required for Kras-induced anchorage-independent growth through regulation of the ERK MAPK signaling pathway. We show that the major source of ROS generation required for anchorage-independent growth is the Q o site of mitochondrial complex III. Furthermore, disruption of mitochondrial function by loss of the mitochondrial transcription factor A (TFAM) gene reduced tumorigenesis in an oncogenic Kras-driven mouse model of lung cancer. These results demonstrate that mitochondrial metabolism and mitochondrial ROS generation are essential for Kras-induced cell proliferation and tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Providing cells with αKG, oxaloacetate, or pyruvate is sufficient to rescue cancer cell proliferation in conditions of glutamine starvation, confirming that glutamine supports proliferation by replenishing depleted TCA cycle intermediates, a process termed anaplerosis (Altman et al., 2016; Weinberg et al., 2010; Yuneva et al., 2007).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Weinberg et al., 2010
Experimental — accuracy not yet measuredIn the citing paper
“However, KRAS has also been shown to promote cancer cell growth by stimulating alanine aminotransferase activity, leading to high levels of α-ketoglutarate for the TCA cycle and mitochondrial ROS generation, which was required for mutant KRAS-driven tumorigenesis in a mouse model of lung cancer64.”
From The metabolic landscape of RAS-driven cancers from biology to therapy (2021) · cites this paper as [64]
In the citing paper
“A low level of reactive oxygen species (ROS) activates tumorigenic growth signaling; however, when the level exceeds the cellular redox capacity, ROS can damage macromolecules such as proteins, lipids and nucleotides55.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [55]
In the citing paper
“Correspondingly, in K-Ras mutant cells, the oxygen consumption rate and ATP generation are enhanced by glutamine, contributing to tumorigenesis55.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [55]
In the citing paper
“Notably, alanine levels were significantly decreased in Mpc knockdown cells, highlighting a role for mitochondrial pyruvate and mitochondrial alanine aminotransferase (ALT2) in mediating glutamine anaplerosis which was previously described in cancer cells (Weinberg et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as Weinberg et al., 2010
In the citing paper
“Another study reported that mitochondrial ROS are necessary for the KRAS (Kirsten rat sarcoma virus)—induced anchored-independent growth of lung cancer.”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Weinberg et al. 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
On Respiratory Impairment in Cancer Cells
Warburg, O. H. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,472
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Cited by
Sorted by citations
Items 501–600 of 1,001
Reactive oxygen species signaling in cancer: comparison with aging.
Afanasʹev, I. B. (2011) · Europe PMC (PubMed Central) · Cited by 83
Liu, X., Boyer, M. A., Holmgren, A. M., & Shin, S. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.07.019 · Cited by 78
The Interplay between ROS and Ras GTPases: Physiological and Pathological Implications
Ferro, E., Goitre, L., Retta, S. F., & Trabalzini, L. (2011) · Journal of Signal Transduction · doi:10.1155/2012/365769 · Cited by 79
Milasta, S., Dillon, C. P., Sturm, O. E., Verbist, K., Brewer, T. L., Quarato, G., Brown, S. A., Frase, S., Janke, L. J., Perry, S. S., et al. (2016) · Immunity · doi:10.1016/j.immuni.2015.12.002 · Cited by 79
Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressures
Graham, N. A., Minasyan, A., Lomova, A., Cass, A. A., Balanis, N. G., Friedman, M., Chan, S. T., Zhao, S. R., Delgado, A., Go, J. L., et al. (2017) · Molecular Systems Biology · doi:10.15252/msb.20167159 · Cited by 78
Sripada, L., Singh, K., Lipatova, A. V., Singh, A., Prajapati, P., Tomar, D., Bhatelia, K., Roy, M., Singh, R. K., Godbole, M. M., et al. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1517-5 · Cited by 79
Mitochondrial Metabolism: Yin and Yang for Tumor Progression
Valcárcel-Jiménez, L., Gaude, E., Torrano, V., Frezza, C., & Carracedo, A. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.06.004 · Cited by 78
Chen, Y., Huang, Y., Zhou, S., Sun, M., Chen, L., Wang, J., Xu, M., Liu, S., Liang, K., Zhang, Q., et al. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c02622 · Cited by 76
Tumour Microenvironment Stress Promotes the Development of Drug Resistance
Seebacher, N. A., Krchniaková, M., Stacy, A. E., Skoda, J., & Jansson, P. J. (2021) · Antioxidants · doi:10.3390/antiox10111801 · Cited by 84
Modulation of macrophage metabolism as an emerging immunotherapy strategy for cancer
Dussold, C., Zilinger, K., Turunen, J. R., Heimberger, A. B., & Miska, J. M. (2024) · Journal of Clinical Investigation · doi:10.1172/jci175445 · Cited by 81
ROS, autophagy, mitochondria and cancer: Ras, the hidden master?
Bellot, G. L., Liu, D., & Pervaiz, S. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.06.007 · Cited by 78
The diverse role of the PPARγ coactivator 1 family of transcriptional coactivators in cancer
Girnun, G. D. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.01.007 · Cited by 76
Amoedo, N. D., Obre, E., & Rossignol, R. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.02.005 · Cited by 76
Beneficial and Detrimental Roles of NLRs in Carcinogenesis
Janowski, A. M., Kolb, R. H., Zhang, W., & Sutterwala, F. S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00370 · Cited by 79
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer
Casacuberta‐Serra, S., González-Larreategui, Í., Capitán-Leo, D., & Soucek, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01907-z · Cited by 84
Quan, Y., Wang, N., Chen, Q., Xu, J., Cheng, W., Di, M., Xia, W., & Gao, W. (2015) · Oncotarget · doi:10.18632/oncotarget.4764 · Cited by 76
Estrogen receptor‐β in mitochondria: implications for mitochondrial bioenergetics and tumorigenesis
Liao, T.-L., Tzeng, C., Yu, C., Wang, Y., & Kao, S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12872 · Cited by 78
Mitochondrial remodeling in cancer metabolism and survival: Potential for new therapies
Barbosa, I. A., Machado, N. G., Skildum, A. J., Scott, P. M., & Oliveira, P. J. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.04.005 · Cited by 81
Maya-Cano, D. A., Arango-Varela, S. S., & Santa-González, G. A. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06297 · Cited by 80
Mitochondria: Insights into Crucial Features to Overcome Cancer Chemoresistance
Genovese, I., Carinci, M., Modesti, L., Aguiari, G., Pinton, P., & Giorgi, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094770 · Cited by 77
Metabolism in cancer metastasis: bioenergetics, biosynthesis, and beyond
Teoh, S. T., & Lunt, S. Y. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1406 · Cited by 77
Zhou, X., Curbo, S., Li, F., Krishnan, S., & Karlsson, A. (2018) · BMC Cancer · doi:10.1186/s12885-018-4443-1 · Cited by 76
Sulfur metabolism and its contribution to malignancy
Ward, N. P., & DeNicola, G. M. (2019) · International review of cytology · doi:10.1016/bs.ircmb.2019.05.001 · Cited by 74
Metabolic rewiring in mutant Kras lung cancer
Kerr, E. M., & Martins, C. P. (2017) · FEBS Journal · doi:10.1111/febs.14125 · Cited by 76
Mitochondria in cancer metabolism, an organelle whose time has come?
Anderson, R. G., Ghiraldeli, L. P., & Pardee, T. S. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.05.005 · Cited by 76
Therapeutic Strategies for Regulating Mitochondrial Oxidative Stress
Yamada, Y., Takano, Y., Satrialdi, S., Abe, J., Hibino, M., & Harashima, H. (2020) · Biomolecules · doi:10.3390/biom10010083 · Cited by 76
Wang, C., Chen, C.-L., Tseng, Y.-L., Fang, Y.-T., Lin, Y.-S., Su, W., Chen, C., Chang, K.-C., Wang, Y., & Lin, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.351957 · Cited by 75
The mitochondrial protein C1qbp promotes cell proliferation, migration and resistance to cell death
McGee, A. M., Douglas, D. L., Liang, Y., Hyder, S. M., & Baines, C. P. (2011) · Cell Cycle · doi:10.4161/cc.10.23.18287 · Cited by 73
Kamiński, M. M., Röth, D., Krammer, P. H., & Gülow, K. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-013-0235-0 · Cited by 73
Gibellini, L., Pinti, M., Boraldi, F., Giorgio, V., Bernardi, P., Bartolomeo, R., Nasi, M., Biasi, S. D., Missiroli, S., Carnevale, G., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-255869 · Cited by 73
Reactive metabolite production is a targetable liability of glycolytic metabolism in lung cancer
Luengo, A., Abbott, K. L., Davidson, S. M., Hosios, A. M., Faubert, B., Chan, S. H., Freinkman, E., Zacharias, L. G., Mathews, T. P., Clish, C. B., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13419-4 · Cited by 75
Metabolic reprogramming and disease progression in cancer patients
Torresano, L., Nuevo‐Tapioles, C., Santacatterina, F., & Cuezva, J. M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165721 · Cited by 73
Natural Agents Targeting Mitochondria in Cancer
Mani, S., Swargiary, G., & Singh, K. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21196992 · Cited by 76
Mitochondria and Viral Infection: Advances and Emerging Battlefronts
Sorouri, M., Chang, T., & Hancks, D. C. (2022) · mBio · doi:10.1128/mbio.02096-21 · Cited by 72
Lu, T., Zhang, Z., Bi, Z., Lan, T., Zeng, H., Liu, Y., Mo, F., Yang, J., Chen, S., He, X., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005430 · Cited by 71
Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence
Nizami, Z. N., Aburawi, H. E., Semlali, A., Muhammad, K., & Iratni, R. (2023) · Antioxidants · doi:10.3390/antiox12061159 · Cited by 78
EglN2 associates with the NRF1‐PGC1α complex and controls mitochondrial function in breast cancer
Zhang, J., Wang, C., Chen, X., Takada, M., Fan, C., Zheng, X., Wen, H., Liu, Y., Wang, C., Pestell, R. G., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201591437 · Cited by 76
Madungwe, N. B., Zilberstein, N., Feng, Y., & Bopassa, J. C. (2016) · PubMed Central · Cited by 71
Guha, M., Srinivasan, S., Raman, P., Jiang, Y., Kaufman, B. A., Taylor, D. M., Dong, D., Chakrabarti, R., Picard, M. A., Carstens, R. P., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.002 · Cited by 73
The Role of Mitochondrial H+-ATP Synthase in Cancer
Esparza‐Moltó, P. B., & Cuezva, J. M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00053 · Cited by 71
TPP-based mitocans: a potent strategy for anticancer drug design
Wang, J., Li, J., Xiao, Y., Fu, B., & Qin, Z. (2020) · RSC Medicinal Chemistry · doi:10.1039/c9md00572b · Cited by 72
Metabolic regulation of the cancer-immunity cycle
Patterson, L. F. S., & Vardhana, S. A. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.09.002 · Cited by 73
Qin, L., Cheng, X., Wang, S., Gong, G., Su, H., Huang, H., Chen, T., Damdinjav, D., Dorjsuren, B., Li, Z., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01093 · Cited by 72
Lin, T.-C., Chen, Y., Kensicki, E., Li, A. Y. J., Kong, M., Li, Y., Mohney, R. P., Shen, H., Stiles, B. L., Mizushima, N., et al. (2012) · Autophagy · doi:10.4161/auto.21228 · Cited by 71
Zheng, W., Li, Z., Nguyen, A. T., Li, C., Emelyanov, A., & Gong, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091179 · Cited by 73
Suppressing Mitochondrial Respiration Is Critical for Hypoxia Tolerance in the Fetal Growth Plate
Yao, Q., Khan, M. P., Merceron, C., LaGory, E. L., Tata, Z., Mangiavini, L., Hu, J., Vemulapalli, K., Chandel, N. S., Giaccia, A. J., et al. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.04.029 · Cited by 71
Self-citationMin, H., Jang, H.-J., Park, K. H., Hyun, S. Y., Park, S. J., Kim, J. H., Son, J., Kang, S. S., & Lee, H. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2041-z · Cited by 75
Metabolic signatures of human breast cancer
Mishra, P., & Ambs, S. (2015) · Molecular & Cellular Oncology · doi:10.4161/23723556.2014.992217 · Cited by 70
Targeting KRAS: The Elephant in the Room of Epithelial Cancers
Merz, V., Gaule, M., Zecchetto, C., Cavaliere, A., Casalino, S., Pesoni, C., Contarelli, S., Sabbadini, F., Bertolini, M., Mangiameli, D., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.638360 · Cited by 74
Reactive oxygen species-upregulating nanomedicines towards enhanced cancer therapy
Ding, Y., Pan, Q., Gao, W., Pu, Y., Luo, K., & He, B. (2022) · Biomaterials Science · doi:10.1039/d2bm01833k · Cited by 71
Targeting KRAS: from metabolic regulation to cancer treatment
Shi, Y., Zheng, H., Wang, T., Zhou, S., Zhao, S., Li, M., & Cao, B. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02216-3 · Cited by 81
Radde, B. N., Ivanova, M. M., Mai, H. X., Salabei, J. K., Hill, B. G., & Klinge, C. M. (2014) · Biochemical Journal · doi:10.1042/bj20131608 · Cited by 70
Mitochondria and Cancer: Past, Present, and Future
Verschoor, M. L., Ungard, R. G., Harbottle, A., Jakupciak, J. P., Parr, R. L., & Singh, G. (2013) · BioMed Research International · doi:10.1155/2013/612369 · Cited by 69
Crosstalk Between ROS and Autophagy in Tumorigenesis: Understanding the Multifaceted Paradox
Hasan, A., Rizvi, S. F., Parveen, S., Pathak, N., Nazir, A., & Mir, S. S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.852424 · Cited by 77
Cancer depends on fatty acids for ATP production: A possible link between cancer and obesity
Lee, H., Woo, S. M., Jang, H., Kang, M., & Kim, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.07.005 · Cited by 71
Cheng, G., & Lanza‐Jacoby, S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.07.118 · Cited by 69
Piserà, A., Campo, A., & Campo, S. (2018) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2018.01.003 · Cited by 70
Energy Metabolism Rewiring Precedes UVB-Induced Primary Skin Tumor Formation
Hosseini, M., Dousset, L., Mahfouf, W., Serrano-Sanchez, M., Redonnet‐Vernhet, I., Mesli, S., Kasraian, Z., Obre, É., Bonneu, M., Claverol, S., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.060 · Cited by 71
Computational Model Predicts the Effects of Targeting Cellular Metabolism in Pancreatic Cancer
Roy, M., & Finley, S. D. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00217 · Cited by 70
Lee, J., Oh, S. J., Choi, H.-J., Kang, J. H., Lee, S.-H., Ha, J. S., Woo, S. M., Jang, H., Lee, H., & Kim, S. (2020) · Cancers · doi:10.3390/cancers12092477 · Cited by 68
Mo, C., Li, ., Yang, S.-X., Guo, H., Liu, Y., Luo, X.-Y., Wang, Y., Li, J., Li, J., & Zou, Q. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0970-z · Cited by 68
Genetic determinants of oxidative stress‐mediated sensitization of drug‐resistant cancer cells
Maiti, A. K. (2011) · International Journal of Cancer · doi:10.1002/ijc.26306 · Cited by 68
Reactive oxygen species: Are they important for haematopoiesis?
Sardina, J. L., López-Ruano, G., Sánchez-Sánchez, B., Llanillo, M., & Hernández‐Hernández, Á. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.03.005 · Cited by 75
Mitochondrial Biogenesis Drives Tumor Cell Proliferation
Martinez‐Outschoorn, U., Pavlides, S., Sotgia, F., & Lisanti, M. P. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.002 · Cited by 68
Ma, J., Liu, B., Yu, D., Zuo, Y., Cai, R., Yang, J., & Cheng, J. (2019) · British Journal of Haematology · doi:10.1111/bjh.16044 · Cited by 68
Berberine Inhibits Growth of Liver Cancer Cells by Suppressing Glutamine Uptake
Zhang, P., Wang, Q., Lin, Z., Yang, P., Dou, K., & Zhang, R. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s235667 · Cited by 68
Pan, J., Lee, Y., Cheng, G., Zielonka, J., Zhang, Q., Bajzíková, M., Xiong, D., Tsaih, S.-W., Hardy, M., Flister, M. J., et al. (2018) · iScience · doi:10.1016/j.isci.2018.04.013 · Cited by 67
Self-citationThe interplay of oncogenic signaling, oxidative stress and ferroptosis in cancer
Zeng, W., Long, X., Liu, P., & Xie, X. (2023) · International Journal of Cancer · doi:10.1002/ijc.34486 · Cited by 70
Enzymatic features of the glucose metabolism in tumor cells
Herling, A., König, M., Bulik, S., & Holzhütter, H. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08174.x · Cited by 70
Chiara, F., Gambalunga, A., Sciacovelli, M., Nicolli, A., Ronconi, L., Fregona, D., Bernardi, P., Rasola, A., & Trevisan, A. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.184 · Cited by 69
Mitochondrial metabolism as a regulator of keratinocyte differentiation
Hamanaka, R. B., & Chandel, N. S. (2013) · Cellular Logistics · doi:10.4161/cl.25456 · Cited by 67
Self-citationIntegrating the UPRmtinto the mitochondrial maintenance network
Fiorese, C. J., & Haynes, C. M. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2017.1291577 · Cited by 68
Wen, H., An, Y., Xu, W. J., Kang, K. W., & Park, S. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201410380 · Cited by 65
Cárdenas, C., Lovy, A., Silva-Pavez, E., Urra, F. A., Mizzoni, C., Ahumada-Castro, U., Bustos, G., Jaña, F., Cruz, P., Farías, P., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aay1212 · Cited by 66
Liu, J., Li, Y., Chen, S., Lin, Y., Lai, H., Chen, B., & Chen, T. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00838 · Cited by 70
Chemotherapy Resistance: Role of Mitochondrial and Autophagic Components
Bahar, E., Han, S., Kim, J., & Yoon, H. (2022) · Cancers · doi:10.3390/cancers14061462 · Cited by 67
Palorini, R., Rasmo, D. D., Gaviraghi, M., Danna, L. S., Signorile, A., Cirulli, C., Chiaradonna, F., Alberghina, L., & Papa, S. (2012) · Oncogene · doi:10.1038/onc.2012.50 · Cited by 68
Mitochondrial Peroxiredoxin III is a Potential Target for Cancer Therapy
Song, I.-S., Kim, H.-K., Jeong, S.-H., Lee, S., Kim, N., Rhee, B. D., Ko, K. S., & Han, J. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12107163 · Cited by 67
Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy
Masamha, C. P., & LaFontaine, P. R. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26814 · Cited by 66
Revisiting vitamin C and cancer
Reczek, C. R., & Chandel, N. S. (2015) · Science · doi:10.1126/science.aad8671 · Cited by 67
Self-citationNew Challenges to Study Heterogeneity in Cancer Redox Metabolism
Benfeitas, R., Uhlén, M., Nielsen, J., & Mardinoğlu, A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00065 · Cited by 67
Li, X., Wang, M., Li, S., Chen, Y., Wang, M., Wu, Z., Sun, X., Yao, L., Dong, H., Song, Y., et al. (2021) · Theranostics · doi:10.7150/thno.57804 · Cited by 66
Recent Perspective of Lactobacillus in Reducing Oxidative Stress to Prevent Disease
Zhao, T., Wang, H., Liu, Z., Liu, Y., DeJi, Li, B., & Huang, X. (2023) · Antioxidants · doi:10.3390/antiox12030769 · Cited by 72
Mambro, T. D., Pellielo, G., Agyapong, E. D., Carinci, M., Chianese, D., Giorgi, C., Morciano, G., Patergnani, S., Pinton, P., & Rimessi, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098181 · Cited by 68
Wild type p53 reactivation: From lab bench to clinic
Selivanova, G. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.03.049 · Cited by 68
Non‐canonical Stat3 signaling in cancer
Srivastava, J., & DiGiovanni, J. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22438 · Cited by 64
Ouyang, Q., Nakayama, T., Baytaş, O., Davidson, S. M., Yang, C., Schmidt, M., Lizarraga, S. B., Mishra, S., El‐Quessny, M., Niaz, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609221113 · Cited by 66
Moran, D. M., Trusk, P. B., Pry, K., Paz, K., Sidransky, D., & Bacus, S. S. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0649 · Cited by 64
Wu, D., Dasgupta, A., Read, A. D., Bentley, R. E. T., Motamed, M., Chen, K., Al‐Qazazi, R., Mewburn, J. D., Dunham‐Snary, K. J., Alizadeh, E., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.452 · Cited by 69
Pachnis, P., Wu, Z., Faubert, B., Tasdogan, A., Gu, W., Shelton, S. D., Solmonson, A., Rao, A. D., Kaushik, A., Rogers, T. J., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn9550 · Cited by 65
N-diethylnitrosamine mouse hepatotoxicity: Time-related effects on histology and oxidative stress
Santos, N. P., Colaço, A. A., da Costa, R. M. G., Oliveira, M. M., Peixoto, F., & Oliveira, P. A. (2014) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2014.07.002 · Cited by 64
The role of mitochondrial electron transport in tumorigenesis and metastasis
Tan, A. S., Baty, J. W., & Berridge, M. V. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.10.016 · Cited by 65
Exhaled breath volatile organic compound biomarkers in lung cancer
Mazzone, P. J. (2012) · Journal of Breath Research · doi:10.1088/1752-7155/6/2/027106 · Cited by 63
O’Keefe, L. V., Colella, A. D., Dayan, S., Chen, Q., Choo, A., Jacob, R. P., Price, G. R., Venter, D. J., & Richards, R. I. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq495 · Cited by 66
Inhibiting mitochondrial respiration prevents cancer in a mouse model of Li-Fraumeni syndrome
Wang, P., Li, J., Walcott, F. L., Kang, J., Starost, M. F., Talagala, S. L., Zhuang, J., Park, J., Huffstutler, R. D., Bryla, C., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci88668 · Cited by 65
Waste Not, Want Not: Lactate Oxidation Fuels the TCA Cycle
Martínez‐Reyes, I., & Chandel, N. S. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.005 · Cited by 66
Self-citationHonokiol targets mitochondria to halt cancer progression and metastasis
Pan, J., Lee, Y., Wang, Y., & You, M. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201501007 · Cited by 62
Perspectives Regarding the Intersections between STAT3 and Oxidative Metabolism in Cancer
Chun, K., Jang, J., & Kim, D. (2020) · Cells · doi:10.3390/cells9102202 · Cited by 62
Targeting Redox Metabolism in Pancreatic Cancer
Hadi, N. A., Reyes‐Castellanos, G., & Carrier, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041534 · Cited by 63
High Expression of Glycolytic Genes in Clinical Glioblastoma Patients Correlates With Lower Survival
Stanke, K. M., Wilson, C., & Kidambi, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.752404 · Cited by 64
Metadata
- Authors
- Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S.
- Affiliations
- Northwestern University (US)
- Division of Pulmonary and Critical Care, Department of Medicine,
- Medical College of Wisconsin (US)
- Department of Biophysics and Free Radical Research Center, Medical College of Wisconsin, Milwaukee, WI 53226
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2010-04-26
- Volume
- 107
- Issue
- 19
- Pages
- 8788-8793
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2889315
- OpenAlex
- W1982330633
- Cited by
- 1,742
- References
- 29
- Citations by year
- 2026: 63 · 2025: 100 · 2024: 124 · 2023: 122 · 2022: 149 · 2021: 154 · 2020: 137 · 2019: 138 · 2018: 111 · 2017: 108 · 2016: 100 · 2015: 113 · 2014: 89 · 2013: 77 · 2012: 77
- FWCI
- 23.58
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX000201)
- LUNGevity Foundation
- Respiratory Health Association of Metropolitan Chicago
- Respiratory Health Association
- National Institutes of Health
- National Heart, Lung, and Blood Institute (P01HL071643)
- National Cancer Institute (R01CA125112, R01CA152810, R01CA123067, CA125112, P30CA060553, T32CA070085, T32CA009560)
- National Institute of Environmental Health Sciences (ES 013995, ES015024, R01ES013995, R01ES015024)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- KRAS, mitochondrial metabolism, reactive oxygen species, pentose phosphate pathway, aerobic glycolysis, Warburg effect, anchorage-independent growth, glutaminase, alpha-ketoglutarate, TCA cycle, ERK signaling, mitochondrial complex III, TFAM, lung cancer, carcinogenesis, hypoxia
- MeSH terms
- Aerobiosis, Animals, Cell Adhesion, Cell Transformation, Neoplastic, Glutamine, Glycolysis, Humans, Lung Neoplasms, Mitochondria, Oxidative Phosphorylation, Pentose Phosphate Pathway, Electron Transport Complex III, Proto-Oncogene Proteins p21(ras), Reactive Oxygen Species, HCT116 Cells, Extracellular Signal-Regulated MAP Kinases, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
